WAVE Life Sciences Ltd R&D Day Transcript
(technical difficulty)
Will be available in the investorsâ action of our website at www.Wavelifesciences.com. Before we begin, I would like to remind you that management may be making forward-looking statements during today's presentation. The statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors that could cause actual results to differ are discussed in our SEC filings, including our ended December 31, 2022, and our quarterly report on Form 10-Q for the quarter ended June 30, 2023. We undertake no obligation to update or revise any forward-looking statements for any reason. Today's agenda features members of the Wave management team, including Paul Bolno, President and CEO; Chandra Vargeese, Chief Technology Officer; Ken Longo, Vice President of Data Science; and Ginnie Yang, Senior Vice President.
Also, joining us today is Carolyn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |